MMV390048 40mg

DRUG2 trials

Sponsors

Medicines for Malaria Venture

Conditions

Malaria

Phase 1

Phase I Study of Ascending Doses of MMV390048 in Healthy Adult Volunteers

CompletedNCT02230579

Medicines for Malaria VentureMalaria

Start: 2014-05-31End: 2015-02-28Updated: 2019-07-17

MMV390048 and Its Antimalarial Activity Against Plasmodium Falciparum in Healthy Adult Subjects, Part B

CompletedNCT02783833

Medicines for Malaria VentureMalaria

Start: 2016-05-31End: 2017-01-16Updated: 2017-02-08

Related Papers

A Phase 1, Placebo-controlled, Randomized, Single Ascending Dose Study and a Volunteer Infection Study to Characterize the Safety, Pharmacokinetics, and Antimalarial Activity of the <i>Plasmodium</i> Phosphatidylinositol 4-Kinase Inhibitor MMV390048

Clinical Infectious Diseases2020-04-0154 citations

Safety, Tolerability, Pharmacokinetics, and Antimalarial Activity of the Novel <i>Plasmodium</i> Phosphatidylinositol 4-Kinase Inhibitor MMV390048 in Healthy Volunteers.

2020-03-2450 citations